- €439.89m
- €706.45m
- €785.69m
- 84
- 50
- 86
- 89
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 817 | 712 | 732 | 753 | 786 |
Cost of Revenue | |||||
Gross Profit | 615 | 545 | 539 | 579 | 610 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 765 | 670 | 693 | 771 | 747 |
Operating Profit | 51.7 | 41.9 | 38.7 | -18.2 | 38.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 51.2 | 22.2 | 29 | -28.4 | 30.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 37.3 | 18.2 | 32.6 | -41.1 | 22.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 37.3 | 18.2 | 32.6 | -41.1 | 23.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 37.3 | 17.7 | 32.6 | -41.1 | 22.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.01 | 1.46 | 2.62 | -0.112 | 1.78 |
Dividends per Share |